Utah Medical Products, Inc. (UTMD)
USD 53.6
(-1.45%)
USD 53.6
(-1.45%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -92.52 Million USD | -23.85% |
| 2022 | -74.71 Million USD | -23.2% |
| 2021 | -60.64 Million USD | -18.32% |
| 2020 | -51.25 Million USD | -20.85% |
| 2019 | -42.41 Million USD | 17.02% |
| 2018 | -51.11 Million USD | -28.18% |
| 2017 | -39.87 Million USD | -51.27% |
| 2016 | -26.36 Million USD | -12.97% |
| 2015 | -23.33 Million USD | -61.31% |
| 2014 | -14.46 Million USD | -171.18% |
| 2013 | -5.33 Million USD | -230.35% |
| 2012 | 4.09 Million USD | -72.85% |
| 2011 | 15.07 Million USD | 186.57% |
| 2010 | -17.41 Million USD | 1.0% |
| 2009 | -17.58 Million USD | -981.16% |
| 2008 | 1.99 Million USD | -30.23% |
| 2007 | 2.86 Million USD | -32.11% |
| 2006 | 4.21 Million USD | -9.04% |
| 2005 | 4.63 Million USD | 354.84% |
| 2004 | -1.81 Million USD | -138.58% |
| 2003 | -762 Thousand USD | -116.31% |
| 2002 | 4.67 Million USD | 119.19% |
| 2001 | 2.13 Million USD | -77.77% |
| 2000 | 9.58 Million USD | 81.31% |
| 1999 | 5.28 Million USD | 211.0% |
| 1998 | 1.7 Million USD | -63.04% |
| 1997 | 4.6 Million USD | 253.33% |
| 1996 | -3 Million USD | 41.18% |
| 1995 | -5.1 Million USD | -218.75% |
| 1994 | -1.6 Million USD | -100.0% |
| 1993 | -800 Thousand USD | 50.0% |
| 1992 | -1.6 Million USD | 0.0% |
| 1991 | -1.6 Million USD | -45.45% |
| 1990 | -1.1 Million USD | -120.0% |
| 1989 | -500 Thousand USD | 83.33% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -93.52 Million USD | -1.08% |
| 2024 Q3 | - USD | 0.89% |
| 2024 Q2 | -88.94 Million USD | 4.9% |
| 2023 Q2 | 630 Thousand USD | -3.96% |
| 2023 Q4 | -92.52 Million USD | -15268.2% |
| 2023 Q3 | 610 Thousand USD | -3.17% |
| 2023 Q1 | 656 Thousand USD | 100.88% |
| 2023 FY | -92.52 Million USD | -23.85% |
| 2022 Q3 | -69.15 Million USD | -5.01% |
| 2022 Q1 | -65.49 Million USD | -7.99% |
| 2022 FY | -74.71 Million USD | -23.2% |
| 2022 Q4 | -74.71 Million USD | -8.03% |
| 2022 Q2 | -65.85 Million USD | -0.56% |
| 2021 Q1 | -55.7 Million USD | -8.68% |
| 2021 Q2 | -59.18 Million USD | -6.25% |
| 2021 Q4 | -60.64 Million USD | 5.21% |
| 2021 FY | -60.64 Million USD | -18.32% |
| 2021 Q3 | -63.97 Million USD | -8.1% |
| 2020 FY | -51.25 Million USD | -20.85% |
| 2020 Q1 | -39.24 Million USD | 7.46% |
| 2020 Q2 | -41.99 Million USD | -7.0% |
| 2020 Q3 | -45.94 Million USD | -9.41% |
| 2020 Q4 | -51.25 Million USD | -11.55% |
| 2019 Q3 | -37 Million USD | -13.92% |
| 2019 Q2 | -32.48 Million USD | -0.7% |
| 2019 Q1 | -32.26 Million USD | 36.88% |
| 2019 FY | -42.41 Million USD | 17.02% |
| 2019 Q4 | -42.41 Million USD | -14.6% |
| 2018 Q2 | -45.87 Million USD | -6.87% |
| 2018 Q4 | -51.11 Million USD | -3.57% |
| 2018 Q3 | -49.35 Million USD | -7.58% |
| 2018 FY | -51.11 Million USD | -28.18% |
| 2018 Q1 | -42.92 Million USD | -7.65% |
| 2017 Q1 | -30.74 Million USD | -16.63% |
| 2017 FY | -39.87 Million USD | -51.27% |
| 2017 Q4 | -39.87 Million USD | -6.29% |
| 2017 Q3 | -37.51 Million USD | -10.96% |
| 2017 Q2 | -33.8 Million USD | -9.97% |
| 2016 Q2 | -29.39 Million USD | -6.83% |
| 2016 Q3 | -31.6 Million USD | -7.53% |
| 2016 Q4 | -26.36 Million USD | 16.6% |
| 2016 Q1 | -27.51 Million USD | -17.93% |
| 2016 FY | -26.36 Million USD | -12.97% |
| 2015 Q2 | -19.16 Million USD | -18.64% |
| 2015 FY | -23.33 Million USD | -61.31% |
| 2015 Q1 | -16.15 Million USD | -11.7% |
| 2015 Q4 | -23.33 Million USD | -7.65% |
| 2015 Q3 | -21.67 Million USD | -13.07% |
| 2014 FY | -14.46 Million USD | -171.18% |
| 2014 Q4 | -14.46 Million USD | -17.5% |
| 2014 Q2 | -8.75 Million USD | -25.86% |
| 2014 Q1 | -6.95 Million USD | -30.37% |
| 2014 Q3 | -12.31 Million USD | -40.66% |
| 2013 FY | -5.33 Million USD | -230.35% |
| 2013 Q3 | -3.95 Million USD | -341.83% |
| 2013 Q2 | -894 Thousand USD | -243.27% |
| 2013 Q1 | 624 Thousand USD | -84.9% |
| 2013 Q4 | -5.33 Million USD | -35.04% |
| 2012 Q2 | 8.57 Million USD | -24.56% |
| 2012 FY | 4.09 Million USD | -72.85% |
| 2012 Q3 | 5.49 Million USD | -35.91% |
| 2012 Q1 | 11.36 Million USD | -24.9% |
| 2012 Q4 | 4.13 Million USD | -24.8% |
| 2011 Q4 | 15.13 Million USD | -10.47% |
| 2011 Q3 | 16.9 Million USD | -14.66% |
| 2011 FY | 15.07 Million USD | 186.57% |
| 2011 Q1 | 20.81 Million USD | 872.61% |
| 2011 Q2 | 19.81 Million USD | -4.81% |
| 2010 FY | -17.41 Million USD | 1.0% |
| 2010 Q1 | -20.25 Million USD | -1710.98% |
| 2010 Q2 | -2.17 Million USD | 89.24% |
| 2010 Q3 | -20.08 Million USD | -821.66% |
| 2010 Q4 | -2.69 Million USD | 86.59% |
| 2009 Q1 | 896 Thousand USD | -55.11% |
| 2009 Q3 | -17.24 Million USD | -12.91% |
| 2009 Q4 | 1.25 Million USD | 107.29% |
| 2009 Q2 | -15.27 Million USD | -1804.35% |
| 2009 FY | -17.58 Million USD | -981.16% |
| 2008 Q2 | 2.85 Million USD | -9.55% |
| 2008 FY | 1.99 Million USD | -30.23% |
| 2008 Q1 | 3.15 Million USD | 10.17% |
| 2008 Q3 | 1.71 Million USD | -39.99% |
| 2008 Q4 | 1.99 Million USD | 16.66% |
| 2007 Q4 | 2.86 Million USD | -15.3% |
| 2007 FY | 2.86 Million USD | -32.11% |
| 2007 Q2 | 3.87 Million USD | -3.9% |
| 2007 Q3 | 3.37 Million USD | -12.78% |
| 2007 Q1 | 4.03 Million USD | -4.37% |
| 2006 Q3 | 4.19 Million USD | -9.3% |
| 2006 Q1 | 4.41 Million USD | -4.62% |
| 2006 Q2 | 4.62 Million USD | 4.62% |
| 2006 Q4 | 4.21 Million USD | 0.5% |
| 2006 FY | 4.21 Million USD | -9.04% |
| 2005 Q2 | -626 Thousand USD | -9.63% |
| 2005 Q4 | 4.63 Million USD | 406.62% |
| 2005 FY | 4.63 Million USD | 354.84% |
| 2005 Q3 | -1.51 Million USD | -141.37% |
| 2005 Q1 | -571 Thousand USD | 68.59% |
| 2004 Q3 | -2.02 Million USD | -54.39% |
| 2004 Q4 | -1.81 Million USD | 10.18% |
| 2004 Q1 | -850 Thousand USD | -11.55% |
| 2004 FY | -1.81 Million USD | -138.58% |
| 2004 Q2 | -1.31 Million USD | -54.24% |
| 2003 FY | -762 Thousand USD | -116.31% |
| 2003 Q1 | 2.68 Million USD | -42.5% |
| 2003 Q2 | 1.56 Million USD | -41.66% |
| 2003 Q4 | -762 Thousand USD | 17.62% |
| 2003 Q3 | -925 Thousand USD | -159.03% |
| 2002 Q4 | 4.67 Million USD | 354.83% |
| 2002 FY | 4.67 Million USD | 119.19% |
| 2002 Q1 | 790 Thousand USD | -62.93% |
| 2002 Q2 | -823 Thousand USD | -204.18% |
| 2002 Q3 | -1.83 Million USD | -122.72% |
| 2001 Q1 | 7.53 Million USD | -21.44% |
| 2001 Q4 | 2.13 Million USD | -49.45% |
| 2001 Q3 | 4.21 Million USD | -34.16% |
| 2001 Q2 | 6.4 Million USD | -14.98% |
| 2001 FY | 2.13 Million USD | -77.77% |
| 2000 Q1 | 3.86 Million USD | -26.9% |
| 2000 Q4 | 9.58 Million USD | -15.55% |
| 2000 Q2 | 3.34 Million USD | -13.56% |
| 2000 FY | 9.58 Million USD | 81.31% |
| 2000 Q3 | 11.35 Million USD | 239.75% |
| 1999 Q4 | 5.28 Million USD | -33.08% |
| 1999 FY | 5.28 Million USD | 211.0% |
| 1999 Q2 | 700 Thousand USD | -36.36% |
| 1999 Q3 | 7.9 Million USD | 1028.57% |
| 1999 Q1 | 1.1 Million USD | -35.29% |
| 1998 Q3 | 3 Million USD | 233.33% |
| 1998 Q4 | 1.7 Million USD | -43.33% |
| 1998 FY | 1.7 Million USD | -63.04% |
| 1998 Q2 | 900 Thousand USD | -66.67% |
| 1998 Q1 | 2.7 Million USD | -41.3% |
| 1997 FY | 4.6 Million USD | 253.33% |
| 1997 Q1 | -1.9 Million USD | 36.67% |
| 1997 Q2 | -200 Thousand USD | 89.47% |
| 1997 Q3 | 5.5 Million USD | 2850.0% |
| 1997 Q4 | 4.6 Million USD | -16.36% |
| 1996 Q3 | -5.1 Million USD | -104.0% |
| 1996 Q2 | -2.5 Million USD | 70.24% |
| 1996 Q1 | -8.4 Million USD | -64.71% |
| 1996 Q4 | -3 Million USD | 41.18% |
| 1996 FY | -3 Million USD | 41.18% |
| 1995 Q4 | -5.1 Million USD | -15.91% |
| 1995 Q1 | -3.8 Million USD | -137.5% |
| 1995 Q2 | -5.3 Million USD | -39.47% |
| 1995 Q3 | -4.4 Million USD | 16.98% |
| 1995 FY | -5.1 Million USD | -218.75% |
| 1994 Q3 | -1.7 Million USD | -183.33% |
| 1994 Q4 | -1.6 Million USD | 5.88% |
| 1994 Q1 | -1.1 Million USD | -37.5% |
| 1994 FY | -1.6 Million USD | -100.0% |
| 1994 Q2 | -600 Thousand USD | 45.45% |
| 1993 Q3 | -1.7 Million USD | -183.33% |
| 1993 Q2 | -600 Thousand USD | 93.41% |
| 1993 Q1 | -9.1 Million USD | -468.75% |
| 1993 Q4 | -800 Thousand USD | 52.94% |
| 1993 FY | -800 Thousand USD | 50.0% |
| 1992 Q2 | -2.7 Million USD | -80.0% |
| 1992 Q1 | -1.5 Million USD | 6.25% |
| 1992 FY | -1.6 Million USD | 0.0% |
| 1992 Q4 | -1.6 Million USD | 61.9% |
| 1992 Q3 | -4.2 Million USD | -55.56% |
| 1991 Q1 | -1 Million USD | 9.09% |
| 1991 FY | -1.6 Million USD | -45.45% |
| 1991 Q2 | -900 Thousand USD | 10.0% |
| 1991 Q3 | -1.7 Million USD | -88.89% |
| 1991 Q4 | -1.6 Million USD | 5.88% |
| 1990 Q3 | -1.4 Million USD | 12.5% |
| 1990 Q4 | -1.1 Million USD | 21.43% |
| 1990 Q2 | -1.6 Million USD | -60.0% |
| 1990 Q1 | -1 Million USD | -100.0% |
| 1990 FY | -1.1 Million USD | -120.0% |
| 1989 FY | -500 Thousand USD | 83.33% |
| 1989 Q2 | -700 Thousand USD | 0.0% |
| 1989 Q3 | 200 Thousand USD | 128.57% |
| 1989 Q4 | -500 Thousand USD | -350.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | 3684.89% |
| AngioDynamics, Inc. | -70.14 Million USD | -31.912% |
| AtriCure, Inc. | -9.81 Million USD | -842.604% |
| Avinger, Inc. | 10.12 Million USD | 1014.289% |
| Azenta, Inc. | -618.47 Million USD | 85.04% |
| BioLife Solutions, Inc. | 7.25 Million USD | 1375.693% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 103.779% |
| Daxor Corporation | 755.65 Thousand USD | 12344.412% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | -6194.286% |
| Femasys Inc. | -15.01 Million USD | -516.216% |
| GlucoTrack, Inc. | -4.29 Million USD | -2053.771% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 340.39% |
| Hologic, Inc. | 374.4 Million USD | 124.713% |
| ICU Medical, Inc. | 1.45 Billion USD | 106.379% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 96.522% |
| KORU Medical Systems, Inc. | -7.03 Million USD | -1214.828% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | -1688.288% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -2058.067% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -2058.067% |
| Masimo Corporation | 804 Million USD | 111.508% |
| Microbot Medical Inc. | -2.28 Million USD | -3947.507% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | -864.24% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 130.615% |
| Nephros, Inc. | -2.47 Million USD | -3644.476% |
| NovoCure Limited | 355.42 Million USD | 126.033% |
| NEXGEL, Inc. | 98 Thousand USD | 94514.286% |
| NEXGEL, Inc. | 98 Thousand USD | 94514.286% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 256.678% |
| OraSure Technologies, Inc. | -276.9 Million USD | 66.585% |
| Pro-Dex, Inc. | 10.91 Million USD | 947.618% |
| Pulse Biosciences, Inc. | -35.22 Million USD | -162.701% |
| Predictive Oncology Inc. | -5.87 Million USD | -1475.757% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | 3154.487% |
| QuidelOrtho Corporation | 2.49 Billion USD | 103.708% |
| Repligen Corporation | -39.51 Million USD | -134.13% |
| Sanara MedTech Inc. | 6.64 Million USD | 1492.438% |
| STAAR Surgical Company | -147.2 Million USD | 37.144% |
| Sharps Technology, Inc. | -3.01 Million USD | -2970.987% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 104.709% |
| Jin Medical International Ltd. | -2.81 Million USD | -3185.132% |